Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy with limited treatment options and poor prognosis. This case report presents the clinical course and management of a 62-year-old man with BPDCN in a resource-limited setting. The patient presented...
Gespeichert in:
Veröffentlicht in: | Oncology (Williston Park, N.Y.) N.Y.), 2024-03, Vol.38 (3), p.104-106 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 106 |
---|---|
container_issue | 3 |
container_start_page | 104 |
container_title | Oncology (Williston Park, N.Y.) |
container_volume | 38 |
creator | Khan, Fiza Hashmi, Foorquan Ghahramanyan, Nerses Baloyan, Elen Tamamyan, Gevorg Konopleva, Marina Pemmaraju, Naveen Voskanyan, Astghik |
description | Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy with limited treatment options and poor prognosis. This case report presents the clinical course and management of a 62-year-old man with BPDCN in a resource-limited setting. The patient presented with constitutional symptoms and abnormal complete blood count findings. Initial treatment was performed with an acute lymphoblastic leukemia-based chemotherapy regimen, and the patient achieved complete remission, but the disease recurred 7 months after the initial diagnosis was confirmed in April 2022. The subsequent therapy was not effective, and the patient died during treatment. This case highlights the challenges in managing BPDCN and the need for further research to improve outcomes. |
doi_str_mv | 10.46883/2024.25921014 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2974003965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A786767261</galeid><sourcerecordid>A786767261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-16ab8db66f1ebf80e1f046bbc0487472af539dcd4c4864d901d487df3fb74ffa3</originalsourceid><addsrcrecordid>eNptks1v1DAQxX0A0VK4ckSWkFAvWezEsZ1j2fIlrQBBOVuOPd66SuzFdg7973Gg5UsrH0ae-c3T0-gh9IySDeNSdq9a0rJN2w8tJZQ9QKdEDqQZyEBP0OOcbwhpOSfyETrpZE8Fo-QUjZde70PMPuyxDhZfJdBl_byedC7e4M-1ztrclugtvoRgk1_bW5gm_BHiYR1jH7DGXyDHJRlodn72BSz-CmWVeoIeOj1leHpXz9C3t2-utu-b3ad3H7YXu8awnpWGcj1KO3LuKIxOEqCOMD6OhjApmGi167vBGssMk5zZgVBbB9Z1bhTMOd2dofNfuocUvy-Qi5p9NtWnDhCXrNpBMEK6gfcVffEfelOth-quUp2kUvSU_KH2egLlg4slabOKqgshueCi5bRSzRFqDwGSnmIA52v7H35zhK_PwuzN0YWXfy1cg57KdY7TUnwM-aiySTHnBE4dkp91ulWUqJ8JUWtC1H1C6sLzuzMs4wz2N34fj-4HuDS05Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2938187510</pqid></control><display><type>article</type><title>Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Khan, Fiza ; Hashmi, Foorquan ; Ghahramanyan, Nerses ; Baloyan, Elen ; Tamamyan, Gevorg ; Konopleva, Marina ; Pemmaraju, Naveen ; Voskanyan, Astghik</creator><creatorcontrib>Khan, Fiza ; Hashmi, Foorquan ; Ghahramanyan, Nerses ; Baloyan, Elen ; Tamamyan, Gevorg ; Konopleva, Marina ; Pemmaraju, Naveen ; Voskanyan, Astghik</creatorcontrib><description>Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy with limited treatment options and poor prognosis. This case report presents the clinical course and management of a 62-year-old man with BPDCN in a resource-limited setting. The patient presented with constitutional symptoms and abnormal complete blood count findings. Initial treatment was performed with an acute lymphoblastic leukemia-based chemotherapy regimen, and the patient achieved complete remission, but the disease recurred 7 months after the initial diagnosis was confirmed in April 2022. The subsequent therapy was not effective, and the patient died during treatment. This case highlights the challenges in managing BPDCN and the need for further research to improve outcomes.</description><identifier>ISSN: 0890-9091</identifier><identifier>DOI: 10.46883/2024.25921014</identifier><identifier>PMID: 38517410</identifier><language>eng</language><publisher>United States: Intellisphere, LLC</publisher><subject>Abdomen ; Antimitotic agents ; Antineoplastic agents ; Blood ; Blood tests ; Bone marrow ; Cancer ; Care and treatment ; Case reports ; Chemotherapy ; Dendritic Cells ; Development and progression ; Diagnosis ; Flow cytometry ; Hematologic Neoplasms - therapy ; Hematology ; Humans ; Induction therapy ; Leukemia ; Lymphatic system ; Male ; Medical diagnosis ; Medical examination ; Medical prognosis ; Middle Aged ; Patients ; Prognosis ; Recurrence ; Remission (Medicine) ; Resource-Limited Settings ; Skin Neoplasms - pathology ; Stem cell transplantation ; Tumors</subject><ispartof>Oncology (Williston Park, N.Y.), 2024-03, Vol.38 (3), p.104-106</ispartof><rights>COPYRIGHT 2024 Intellisphere, LLC</rights><rights>Copyright MultiMedia Healthcare Inc. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38517410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Fiza</creatorcontrib><creatorcontrib>Hashmi, Foorquan</creatorcontrib><creatorcontrib>Ghahramanyan, Nerses</creatorcontrib><creatorcontrib>Baloyan, Elen</creatorcontrib><creatorcontrib>Tamamyan, Gevorg</creatorcontrib><creatorcontrib>Konopleva, Marina</creatorcontrib><creatorcontrib>Pemmaraju, Naveen</creatorcontrib><creatorcontrib>Voskanyan, Astghik</creatorcontrib><title>Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting</title><title>Oncology (Williston Park, N.Y.)</title><addtitle>Oncology (Williston Park)</addtitle><description>Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy with limited treatment options and poor prognosis. This case report presents the clinical course and management of a 62-year-old man with BPDCN in a resource-limited setting. The patient presented with constitutional symptoms and abnormal complete blood count findings. Initial treatment was performed with an acute lymphoblastic leukemia-based chemotherapy regimen, and the patient achieved complete remission, but the disease recurred 7 months after the initial diagnosis was confirmed in April 2022. The subsequent therapy was not effective, and the patient died during treatment. This case highlights the challenges in managing BPDCN and the need for further research to improve outcomes.</description><subject>Abdomen</subject><subject>Antimitotic agents</subject><subject>Antineoplastic agents</subject><subject>Blood</subject><subject>Blood tests</subject><subject>Bone marrow</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>Dendritic Cells</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Flow cytometry</subject><subject>Hematologic Neoplasms - therapy</subject><subject>Hematology</subject><subject>Humans</subject><subject>Induction therapy</subject><subject>Leukemia</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical examination</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Recurrence</subject><subject>Remission (Medicine)</subject><subject>Resource-Limited Settings</subject><subject>Skin Neoplasms - pathology</subject><subject>Stem cell transplantation</subject><subject>Tumors</subject><issn>0890-9091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptks1v1DAQxX0A0VK4ckSWkFAvWezEsZ1j2fIlrQBBOVuOPd66SuzFdg7973Gg5UsrH0ae-c3T0-gh9IySDeNSdq9a0rJN2w8tJZQ9QKdEDqQZyEBP0OOcbwhpOSfyETrpZE8Fo-QUjZde70PMPuyxDhZfJdBl_byedC7e4M-1ztrclugtvoRgk1_bW5gm_BHiYR1jH7DGXyDHJRlodn72BSz-CmWVeoIeOj1leHpXz9C3t2-utu-b3ad3H7YXu8awnpWGcj1KO3LuKIxOEqCOMD6OhjApmGi167vBGssMk5zZgVBbB9Z1bhTMOd2dofNfuocUvy-Qi5p9NtWnDhCXrNpBMEK6gfcVffEfelOth-quUp2kUvSU_KH2egLlg4slabOKqgshueCi5bRSzRFqDwGSnmIA52v7H35zhK_PwuzN0YWXfy1cg57KdY7TUnwM-aiySTHnBE4dkp91ulWUqJ8JUWtC1H1C6sLzuzMs4wz2N34fj-4HuDS05Q</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Khan, Fiza</creator><creator>Hashmi, Foorquan</creator><creator>Ghahramanyan, Nerses</creator><creator>Baloyan, Elen</creator><creator>Tamamyan, Gevorg</creator><creator>Konopleva, Marina</creator><creator>Pemmaraju, Naveen</creator><creator>Voskanyan, Astghik</creator><general>Intellisphere, LLC</general><general>MultiMedia Healthcare Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20240301</creationdate><title>Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting</title><author>Khan, Fiza ; Hashmi, Foorquan ; Ghahramanyan, Nerses ; Baloyan, Elen ; Tamamyan, Gevorg ; Konopleva, Marina ; Pemmaraju, Naveen ; Voskanyan, Astghik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-16ab8db66f1ebf80e1f046bbc0487472af539dcd4c4864d901d487df3fb74ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>Antimitotic agents</topic><topic>Antineoplastic agents</topic><topic>Blood</topic><topic>Blood tests</topic><topic>Bone marrow</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>Dendritic Cells</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Flow cytometry</topic><topic>Hematologic Neoplasms - therapy</topic><topic>Hematology</topic><topic>Humans</topic><topic>Induction therapy</topic><topic>Leukemia</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical examination</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Recurrence</topic><topic>Remission (Medicine)</topic><topic>Resource-Limited Settings</topic><topic>Skin Neoplasms - pathology</topic><topic>Stem cell transplantation</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Fiza</creatorcontrib><creatorcontrib>Hashmi, Foorquan</creatorcontrib><creatorcontrib>Ghahramanyan, Nerses</creatorcontrib><creatorcontrib>Baloyan, Elen</creatorcontrib><creatorcontrib>Tamamyan, Gevorg</creatorcontrib><creatorcontrib>Konopleva, Marina</creatorcontrib><creatorcontrib>Pemmaraju, Naveen</creatorcontrib><creatorcontrib>Voskanyan, Astghik</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Oncology (Williston Park, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Fiza</au><au>Hashmi, Foorquan</au><au>Ghahramanyan, Nerses</au><au>Baloyan, Elen</au><au>Tamamyan, Gevorg</au><au>Konopleva, Marina</au><au>Pemmaraju, Naveen</au><au>Voskanyan, Astghik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting</atitle><jtitle>Oncology (Williston Park, N.Y.)</jtitle><addtitle>Oncology (Williston Park)</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>38</volume><issue>3</issue><spage>104</spage><epage>106</epage><pages>104-106</pages><issn>0890-9091</issn><abstract>Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy with limited treatment options and poor prognosis. This case report presents the clinical course and management of a 62-year-old man with BPDCN in a resource-limited setting. The patient presented with constitutional symptoms and abnormal complete blood count findings. Initial treatment was performed with an acute lymphoblastic leukemia-based chemotherapy regimen, and the patient achieved complete remission, but the disease recurred 7 months after the initial diagnosis was confirmed in April 2022. The subsequent therapy was not effective, and the patient died during treatment. This case highlights the challenges in managing BPDCN and the need for further research to improve outcomes.</abstract><cop>United States</cop><pub>Intellisphere, LLC</pub><pmid>38517410</pmid><doi>10.46883/2024.25921014</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0890-9091 |
ispartof | Oncology (Williston Park, N.Y.), 2024-03, Vol.38 (3), p.104-106 |
issn | 0890-9091 |
language | eng |
recordid | cdi_proquest_miscellaneous_2974003965 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Abdomen Antimitotic agents Antineoplastic agents Blood Blood tests Bone marrow Cancer Care and treatment Case reports Chemotherapy Dendritic Cells Development and progression Diagnosis Flow cytometry Hematologic Neoplasms - therapy Hematology Humans Induction therapy Leukemia Lymphatic system Male Medical diagnosis Medical examination Medical prognosis Middle Aged Patients Prognosis Recurrence Remission (Medicine) Resource-Limited Settings Skin Neoplasms - pathology Stem cell transplantation Tumors |
title | Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T13%3A30%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosing%20and%20Treating%20Blastic%20Plasmacytoid%20Dendritic%20Cell%20Neoplasm%20in%20a%20Resource-Limited%20Setting&rft.jtitle=Oncology%20(Williston%20Park,%20N.Y.)&rft.au=Khan,%20Fiza&rft.date=2024-03-01&rft.volume=38&rft.issue=3&rft.spage=104&rft.epage=106&rft.pages=104-106&rft.issn=0890-9091&rft_id=info:doi/10.46883/2024.25921014&rft_dat=%3Cgale_proqu%3EA786767261%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2938187510&rft_id=info:pmid/38517410&rft_galeid=A786767261&rfr_iscdi=true |